Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-26-013298
Filing Date
2026-03-27
Accepted
2026-03-27 17:28:57
Documents
71
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A form10-ka.htm   iXBRL 10-K/A 982651
2 EX-23.1 ex23-1.htm EX-23.1 3566
3 EX-23.1 ex31-1.htm EX-23.1 6461
4 EX-31.2 ex31-2.htm EX-31.2 6542
5 EX-32.1 ex32-1.htm EX-32.1 10147
  Complete submission text file 0001493152-26-013298.txt   6584156

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE immx-20251231.xsd EX-101.SCH 54253
7 XBRL CALCULATION FILE immx-20251231_cal.xml EX-101.CAL 70720
8 XBRL DEFINITION FILE immx-20251231_def.xml EX-101.DEF 221316
9 XBRL LABEL FILE immx-20251231_lab.xml EX-101.LAB 518350
10 XBRL PRESENTATION FILE immx-20251231_pre.xml EX-101.PRE 394722
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 977327
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41159 | Film No.: 26808733
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)